Expansion of the CME CF Cryptocurrency Pricing Products Family to include Ondo Finance, SUI, Arbitrum, NEAR and Polkadot Reference Rates and Real-Time indices

The Administrator announces the addition of several Reference Rates and Real-Time indices to the CME CF Cryptocurrency Pricing Products Family.

Expansion of the CME CF Cryptocurrency Pricing Products Family to include Ondo Finance, SUI, Arbitrum, NEAR and Polkadot Reference Rates and Real-Time indices

The Administrator announces the addition of the Reference Rates and Real-Time indices listed below, to the CME CF Cryptocurrency Pricing Products Family.

Benchmark Ticker
CME CF Ondo Finance-Dollar Reference RateONDOUSD_RR
CME CF Ondo Finance- Dollar Reference Rate – New York VariantONDOUSD_NY
CME CF Ondo Finance-Dollar Real Time IndexONDOUSD_RTI
CME CF SUI-Dollar Reference RateSUIUSD_RR
CME CF SUI-Dollar Reference Rate – New York VariantSUIUSD_NY
CME CF SUI-Dollar Real Time IndexSUIUSD_RTI
CME CF Arbitrum-Dollar Reference RateARBUSD_RR
CME CF Arbitrum-Dollar Real Time IndexARBUSD_RTI
CME CF NEAR-Dollar Reference RateNEARUSD_RR
CME CF NEAR-Dollar Real Time IndexNEARUSD_RTI
CME CF Polkadot-Dollar Reference Rate – Asia Pacific VariantDOTUSD_AP

Each Reference Rate will publish the U.S. dollar price of its respective digital asset, once a day, at either 16:00 London Time, 16:00 New York Time (for New York Variants), or 16:00 Hong Kong Time (for Asia Pacific Variants).

Real-Time Index prices will be published once per second, 24 hours a day, 365 days a year.

Publication of these indices will commence on June 9th, 2025.

The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell any of the underlying instruments cited including but not limited to cryptoassets, financial instruments or any instruments that reference any index provided by CF Benchmarks Ltd. This communication is not intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. Please contact your financial adviser or professional before making an investment decision.